Physician profile
Carissa Thomas
NPI 1306289103
$4,412.88
in general payments reported to CMS, 2019-2025
7 companies · $2,026 in 2025
The $2,026 reported for 2025 was more than what 91% of Plastic Surgery Within The Head & Neck providers received nationally (typical 2025 total: $238).
See the full distribution for Plastic Surgery within the Head & Neck
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.63 · 2020: $494 · 2022: $1,112 · 2023: $289 · 2024: $448 · 2025: $2,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,000 · Food and Beverage: $763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,000.00 |
| Food and Beverage | $762.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $2,348.44 | 2024-2025 | |
| Stryker Corporation | $923.56 | 2022-2023 | Na, Vsp System, Vsp Cranial, Universal Neuro 2 |
| Depuy Synthes Sales INC. | $681.93 | 2020-2025 | Trumatch, Na |
| Baxter Healthcare | $267.58 | 2022 | |
| Axogen | $112.24 | 2020 | |
| Smith+Nephew, INC. | $52.27 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $26.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carissa Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.